PROSTATE CANCER

New safety in the use and pancreatic cancer vaccine-induced immune response Baltimore, Johns Hopkins Medical Association's Dr. Elizabeth M. Jaffee and his colleagues on the 14 cases eight weeks before the trip P...

Combination of radiotherapy and chemotherapy in patients with advanced pancreatic cancer will regain hope surgery The University of Michigan Medical School and his colleagues, Dr. JB Ammori that radiotherapy combined gemcitabine (Gem / RT) as a new mean...

Johns Hopkins University School of Medicine study of 14 patients with pancreatic cancer vaccine experiment. Pancreatic cancer surgery removed the tumor, 14 patients received different doses of the vaccine. Research found that the largest dose of the vaccine in patients with the three parts of the immune system is activated in the diagnosis after 30 months without recurrence symptoms, and 11 were no obvious response. After vaccination side effects of the injection site within a few days localized skin reaction, redness, itching and so on.

The leadership of the Clinical Oncology, Doctor of Medicine, Professor Elizabeth Jefferson said: "This study is only the first step. But we found that the vaccine is safe, but after reaching a certain dose really immune response. Results have been encouraging. "

Researchers will join the GM-CSF gene pancreatic cancer cells acquire such vaccines. GM-CSF gene activation of the immune system is the most effective gene, it can attract immune cells to the surface antigen accumulation of the tumor cells. These antigen in the immune system can identify and guide the residual damage in patients in other locations of cancer.

Jefferson said: "If these transgenic vaccine can be used to help eradicate surgery, chemotherapy and radiotherapy after residual cancer cells. We need to find the best combination of treatments, to provide patients with the greatest chance of survival. "

But the researchers also said, to the ultimate test the effectiveness of the vaccine also require in-depth study and assessment. Johns Hopkins University will begin in the summer of 2001 for the second phase of the vaccine experiment.

According to statistics, the United States every year about 28,000 people died of pancreatic cancer, no more than 5% of the pancreatic cancer patients can live more than five years.

Endoscopic ultrasound localization biopsy for pancreatic cancer is the discovery of an excellent supplementary means Indiana University in the United States a prospective study showed that, for biopsy specimens negative cytology results for the pancreatic ...

Vegetarian low probability of prostate cancer According to the Oxford Royal Cancer Research Foundation study that vegetarian men suffering from prostate cancer lower. The researchers sa...

Intraoperative radiation therapy of pancreatic cancer-research center Japan's Tokyo Komagome Hospital Dr. Okamoto and his colleagues selected 144 cases of pancreatic cancer patients, intraoperative radioth...

Pancreatic cancer laparoscopy reduce unnecessary laparotomy Tel Aviv E. Wolfson Medical Center Dr. Pinhas P. Schachter and his colleagues evaluated laparoscopy and laparoscopic ultrasonography (EH ul...

Gene mutation may lead to prostate cancer British scientists discovered a new study, men in a "BRCA2," if the gene variation arising from defects, with the risk of prostate...

Appropriate exercise can prevent prostate cancer Movement is not only beneficial to the heart, the prevention of prostate cancer also have benefits; A new study shows that the conduct of c...

The diagnosis and differential diagnosis

Non-steroidal anti-inflammatory drug can prevent prostate cancer